Market Overview:
The global glycated albumin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about early diagnosis and treatment of diabetes, and technological advancements in glycated albumin detection methods. Based on type, the global glycated albumin market is segmented into human and animal. The human segment is expected to account for the majority share of the global glycated albumin market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to increasing incidence rates of diabetes across all regions worldwide. On the other hand, animal-derived glycation proteins are used as an immunological adjuvant for cancer therapy and are also being investigated as potential vaccine candidates against various infectious diseases such as HIV, malaria, tuberculosis, etc., which is anticipated propel growth in this segment over the forecast period (2018-2030).
Product Definition:
A glycated protein is a protein that has been modified by the addition of a sugar molecule. Albumin is a glycoprotein that is found in blood plasma. When albumin binds to glucose, it forms glycated albumin. Glycated albumin is used as a marker of long-term blood glucose control in people with diabetes mellitus.
Glycated Albumin (Human):
Glycated albumin (human) is a form of protein, which is found in the blood vessels and liver. It helps maintain the correct fluid balance in the body by transporting excess water along with it. The human version of this product has a very low rate of absorption compared to other species’ versions.
Glycated Albumin (Animal):
Glycated albumin is a form of protein that is found in the liver and kidneys. It is also produced in the human body, however, at an extremely low rate compared to animal-derived glycated albumin. Glycated albumin has several functions including transporting amino acids into cells and aiding in the removal of toxins from cells; it also helps maintain blood glucose levels by facilitating its uptake into cells.
Application Insights:
The hospitals and clinics segment held the largest market share in 2017. This is attributed to the rising prevalence of chronic diseases such as cardiovascular, respiratory, diabetes mellitus which involves a high requirement of protein in diet. Furthermore, increasing healthcare spending by governments as well as individuals is expected to fuel industry growth over the forecast period.
The laboratories application segment is expected to witness lucrative growth over the forecast period owing to an increase in demand for glycated albumin tests across various applications including food testing and drug discovery & development. Glycated albumin plays a significant role in maintaining normal blood glucose levels and its deficiency may lead to hyperglycemia or hypoglycemia respectively. Thus, glycated albumin has wide applications across different industries including pharmaceuticals and food processing which includes analysis of drugs for glycemic properties etcetera (i).
Regional Analysis:
North America was the largest market for the product and accounted for a revenue share of over 35.0% in 2017 owing to high demand from hospitals and clinics along with rising prevalence of diabetes in this region. The U.S., being one of the most developed nations, has witnessed a significant increase in chronic diseases that require regular monitoring and treatment using advanced products such as glycated albumin, thereby driving growth over last few years.
Growth Factors:
- Increasing prevalence of diabetes and other chronic diseases: The global prevalence of diabetes is expected to increase from 9% in 2010 to 11% by 2030. This will create a large pool of patients with glycated albumin, which will drive the demand for this product.
- Rising awareness about the benefits of early diagnosis and treatment: There is an increasing awareness among healthcare professionals and patients about the benefits of early diagnosis and treatment for chronic diseases such as diabetes. This is likely to lead to an increase in demand for glycated albumin products.
- Technological advancements in glycation detection methods: There have been significant advancements in glycation detection methods over the past few years, which has led to an increase in accuracy levels and a reduction in costs associated with these tests. This is likely to result in increased use of glycated albumin products across all settings, including hospitals, clinics, research laboratories etcetera .
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycated Albumin Market Research Report
By Type
Glycated Albumin (Human), Glycated Albumin (Animal)
By Application
Hospitals and Clinics, Laboratories
By Companies
Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura, Leadman, Simes Sikma, NINGBO PUREBIO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Glycated Albumin Market Report Segments:
The global Glycated Albumin market is segmented on the basis of:
Types
Glycated Albumin (Human), Glycated Albumin (Animal)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Asahi Kasei Pharma
- DIAZYME
- Abnova
- LifeSpan
- Exocell
- BSBE
- Medicalsystem
- Maccura
- Leadman
- Simes Sikma
- NINGBO PUREBIO
Highlights of The Glycated Albumin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glycated Albumin (Human)
- Glycated Albumin (Animal)
- By Application:
- Hospitals and Clinics
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycated Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycated albumin is a protein that has been glycated, or cross-linked with glucose. Glycation occurs when the body produces too much sugar and attaches it to proteins, causing them to become stiffer and more difficult for the body to break down. This can lead to inflammation and other health problems.
Some of the major companies in the glycated albumin market are Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura, Leadman, Simes Sikma, NINGBO PUREBIO.
The glycated albumin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Glycated Albumin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Glycated Albumin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Glycated Albumin Market - Supply Chain
4.5. Global Glycated Albumin Market Forecast
4.5.1. Glycated Albumin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Glycated Albumin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Glycated Albumin Market Absolute $ Opportunity
5. Global Glycated Albumin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Glycated Albumin Market Size and Volume Forecast by Type
5.3.1. Glycated Albumin (Human)
5.3.2. Glycated Albumin (Animal)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Glycated Albumin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Glycated Albumin Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinics
6.3.2. Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Glycated Albumin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Glycated Albumin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Glycated Albumin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Glycated Albumin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Glycated Albumin Demand Share Forecast, 2019-2026
9. North America Glycated Albumin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Glycated Albumin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Glycated Albumin Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinics
9.4.2. Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Glycated Albumin Market Size and Volume Forecast by Type
9.7.1. Glycated Albumin (Human)
9.7.2. Glycated Albumin (Animal)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Glycated Albumin Demand Share Forecast, 2019-2026
10. Latin America Glycated Albumin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Glycated Albumin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Glycated Albumin Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinics
10.4.2. Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Glycated Albumin Market Size and Volume Forecast by Type
10.7.1. Glycated Albumin (Human)
10.7.2. Glycated Albumin (Animal)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Glycated Albumin Demand Share Forecast, 2019-2026
11. Europe Glycated Albumin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Glycated Albumin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Glycated Albumin Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinics
11.4.2. Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Glycated Albumin Market Size and Volume Forecast by Type
11.7.1. Glycated Albumin (Human)
11.7.2. Glycated Albumin (Animal)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Glycated Albumin Demand Share, 2019-2026
12. Asia Pacific Glycated Albumin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Glycated Albumin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Glycated Albumin Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinics
12.4.2. Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Glycated Albumin Market Size and Volume Forecast by Type
12.7.1. Glycated Albumin (Human)
12.7.2. Glycated Albumin (Animal)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Glycated Albumin Demand Share, 2019-2026
13. Middle East & Africa Glycated Albumin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Glycated Albumin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Glycated Albumin Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinics
13.4.2. Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Glycated Albumin Market Size and Volume Forecast by Type
13.7.1. Glycated Albumin (Human)
13.7.2. Glycated Albumin (Animal)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Glycated Albumin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Glycated Albumin Market: Market Share Analysis
14.2. Glycated Albumin Distributors and Customers
14.3. Glycated Albumin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Asahi Kasei Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DIAZYME
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abnova
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LifeSpan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Exocell
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BSBE
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medicalsystem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Maccura
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Leadman
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Simes Sikma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NINGBO PUREBIO
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
